{"id":2653,"date":"2024-10-23T12:22:04","date_gmt":"2024-10-23T10:22:04","guid":{"rendered":"https:\/\/steinbeis-finance.de\/en\/?post_type=partner&p=2653"},"modified":"2024-10-25T15:48:11","modified_gmt":"2024-10-25T13:48:11","slug":"dr-christopher-klein","status":"publish","type":"partner","link":"https:\/\/steinbeis-finance.de\/en\/team\/partner\/dr-christopher-klein","title":{"rendered":"Dr. Christopher Klein"},"content":{"rendered":"\n
Dr. Christopher Klein is a partner at Steinbeis M&A Partners GmbH with a committed focus on Healthcare.<\/p>\n\n\n\n
He learnt the M&A gamut at Arthur Andersen and Ernst & Young, then moved to the industry for 20 years as a corporate developer and executive manager (pharma-biotech-medtech of all sizes) and returned to the advisory profession in 2024.<\/p>\n\n\n\n
Previously, Christopher was:<\/p>\n\n\n\n
He holds degrees in biotechnology and business administration following his studies at TU Braunschweig, FernUni Hagen, University College London and Technical University of Denmark.<\/p>\n\n\n\n
Due to his cultural interests and family, he is multilingual and a cosmopolitan. His heart beats for trains. In addition to railway and traveling, he also enjoys photography, baroque music and outdoor activities.<\/p>\n","protected":false},"featured_media":2655,"template":"","class_list":["post-2653","partner","type-partner","status-publish","has-post-thumbnail","hentry"],"yoast_head":"\n